Dario Health Digital Therapeutics API

Dario Health digital therapeutics REST API for health plans, employers, and health systems to deliver AI-powered chronic disease management for diabetes, hypertension, musculoskeletal conditions, and behavioral health. Enables AI agents to manage member enrollment and onboarding for digital therapeutics program automation, handle blood glucose monitoring data integration for diabetes management automation, access real-time biometric data from Dario smart devices for RPM automation, retrieve personalized coaching session scheduling and delivery for chronic disease engagement automation, manage condition-specific intervention pathway assignment for digital therapeutics protocol automation, handle claims and utilization data integration for health plan population health automation, access behavioral health check-in and mood tracking for mental health digital therapeutics automation, retrieve A1C and lab value integration for longitudinal diabetes outcomes automation, manage employer wellness program enrollment and engagement for workforce health automation, and integrate Dario with health plan claims systems, EHRs, and benefits platforms for end-to-end chronic disease program management.

Evaluated Mar 07, 2026 (0d ago) vcurrent
Homepage ↗ Other dario digital-therapeutics diabetes RPM chronic-disease DTx
⚙ Agent Friendliness
49
/ 100
Can an agent use this?
🔒 Security
71
/ 100
Is it safe for agents?
⚡ Reliability
62
/ 100
Does it work consistently?

Score Breakdown

⚙ Agent Friendliness

MCP Quality
12
Documentation
62
Error Messages
60
Auth Simplicity
63
Rate Limits
60

🔒 Security

TLS Enforcement
90
Auth Strength
68
Scope Granularity
65
Dep. Hygiene
62
Secret Handling
67

DTx platform. HIPAA, SOC2, FDA-registered. OAuth2. US. Biometric, chronic disease, and behavioral health PHI.

⚡ Reliability

Uptime/SLA
63
Version Stability
63
Breaking Changes
60
Error Recovery
62
AF Security Reliability

Best When

A health plan, employer, or health system wanting AI agents to automate chronic disease digital therapeutics delivery, biometric monitoring, personalized coaching engagement, and population health reporting within Dario's DTx platform.

Avoid When

FDA SOFTWARE AS MEDICAL DEVICE FOR DIABETES MANAGEMENT: Dario Health's AI-powered diabetes coaching features may constitute Software as a Medical Device (SaMD); automated clinical recommendations based on Dario glucose data that suggest medication adjustment without physician oversight creates FDA SaMD classification risk. HIPAA MINIMUM NECESSARY FOR CHRONIC DISEASE PHI: Automated access to Dario member biometric, behavioral health, and chronic disease data constitutes sensitive PHI categories; automated data pipelines must implement minimum necessary standard; behavioral health data accessed via Dario integration requires heightened protection under state mental health parity laws. ADA/AADE CLINICAL GUIDELINE AUTOMATION RISK: Automated diabetes coaching via Dario that contradicts current ADA Standards of Medical Care creates clinical liability exposure; ensure automated coaching protocols are reviewed against current ADA guidelines before deployment.

Use Cases

  • Managing diabetes members from chronic disease automation agents
  • Tracking biometrics from RPM digital therapeutics agents
  • Enrolling employees from employer wellness automation agents
  • Reporting clinical outcomes from health plan population health agents

Not For

  • FDA Class II/III medical device data (use clinical-grade device APIs)
  • Inpatient chronic disease management
  • Research-grade clinical trial data collection (use Medidata or Veeva)

Interface

REST API
Yes
GraphQL
No
gRPC
No
MCP Server
No
SDK
Yes
Webhooks
Yes

Authentication

Methods: oauth
OAuth: Yes Scopes: Yes

Dario Health uses OAuth 2.0 with scopes. REST API with JSON and mobile SDKs for patient-facing apps. New York HQ. Founded 2011 as LabStyle Innovations, rebranded to DarioHealth in 2015. Public (NASDAQ: DRIO). Digital therapeutics for diabetes, hypertension, musculoskeletal, and behavioral health. Smart glucometer device + app platform. Health plan and employer channel partnerships. FHIR output for EHR integration. HIPAA Business Associate. Competes with Omada Health, Livongo (now Teladoc Health), and Noom for digital chronic disease management.

Pricing

Model: subscription
Free tier: No
Requires CC: No

New York NY. Public (NASDAQ: DRIO). Per-member monthly subscription. Health plan and employer channel. Device + DTx bundle. No free tier.

Agent Metadata

Pagination
cursor
Idempotent
Partial
Retry Guidance
Not documented

Known Gotchas

  • GLUCOMETER DEVICE PAIRING ACTIVATION REQUIREMENT: Dario smart glucometer requires physical device activation before member biometric data flows via API; automated member enrollment via Dario API creates member record but does not activate device data stream; device kit shipment and physical activation is prerequisite for automated biometric data collection; automated RPM workflows must verify device activation status before expecting glucose readings
  • BEHAVIORAL HEALTH DATA STATE LAW LAYERING: Dario behavioral health module data involves mental health and substance use data; state mental health confidentiality laws (e.g., California Welfare and Institutions Code 5328, New York Mental Hygiene Law) impose additional restrictions beyond HIPAA; automated data sharing of behavioral health component data to third-party systems must verify state-specific consent requirements beyond the Dario HIPAA BAA
  • HEALTH PLAN ELIGIBILITY SYNC LAG: Dario member eligibility for health plan programs is driven by eligibility file feeds from health plans; automated coaching session scheduling or biometric alert triggering for terminated members creates engagement with ineligible members; implement eligibility status check in automated workflows with tolerance for 24-48 hour eligibility file lag
  • DUAL CONDITION OVERLAP IN DTx PATHWAY ASSIGNMENT: Dario supports multiple chronic conditions per member; automated pathway assignment for members with comorbid diabetes and hypertension must handle dual enrollment; automated single-pathway assignment for multi-condition members misses condition-specific intervention opportunities available through Dario's comorbidity management capabilities
  • NASDAQ DRIO SMALL CAP PLATFORM RISK: Dario Health is a small-cap public company (NASDAQ: DRIO); financial stability and platform investment capacity is more constrained than large health plan vendors; evaluate platform sustainability for long-term automated workflow dependency before building complex enterprise integrations on Dario

Alternatives

Full Evaluation Report

Comprehensive deep-dive: security analysis, reliability audit, agent experience review, cost modeling, competitive positioning, and improvement roadmap for Dario Health Digital Therapeutics API.

AI-powered analysis · PDF + markdown · Delivered within 30 minutes

$99

Package Brief

Quick verdict, integration guide, cost projections, gotchas with workarounds, and alternatives comparison.

Delivered within 10 minutes

$3

Score Monitoring

Get alerted when this package's AF, security, or reliability scores change significantly. Stay ahead of regressions.

Continuous monitoring

$3/mo

Scores are editorial opinions as of 2026-03-07.

6470
Packages Evaluated
26150
Need Evaluation
173
Need Re-evaluation
Community Powered